Douglas Thorburn

9PUBLICATIONS
85CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)GlycoconjugatesGastroenterology and hepatologyPredictive and prognostic markersChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 19, 2025
Nebokitug, an Anti-chemokine (C-C Motif) Ligand 24 Monoclonal Antibody, in Patients With Primary Sclerosing Cholangitis: A Phase 2 Study.

Christopher L Bowlus, Douglas Thorburn, Stephen T Barclay

|Jan 31, 2025
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.

Bishoi Aziz, Beverley Kok, Matthew Cheah

|Jul 25, 2024
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.

Bishoi Aziz, Beverley Kok, Matthew Cheah

|Mar 20, 2024
Primary biliary cholangitis drug evaluation and regulatory approval: Where do we go from here?

David E J Jones, Ulrich Beuers, Alan Bonder

Pageof 2